Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
DoD Breast Cancer Breakthrough Award Level 3
Summary:
Supports promising research that has high potential to lead to or make breakthroughs in breast cancer.
All applications must address at least one of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) overarching challenges, unless adequate justification for exception is provided.
Applications must address the challenge in a way that can lead to or make a breakthrough and have major impact.
The FY25 Breakthrough Award mechanism contains three different funding levels designed to support major (but not all) stages of research that will lead to clinical application.
Each level has a defined research scope.
The current program announcement discusses the Breakthrough Award Level 3. Distinctive Features:· For this funding mechanism, small-scale clinical trials are allowed but not required.
Applications proposing projects with a clinical trial should be submitted under the Clinical Trial option.· The research team must include two or more breast cancer consumer advocates.· This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI.
For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage.
Be advised, applications may be withdrawn if both the initiating and partnering applications are not submitted by the full application deadline or if the initiating or partnering application is administratively withdrawn.
Supports promising research that has high potential to lead to or make breakthroughs in breast cancer.
All applications must address at least one of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) overarching challenges, unless adequate justification for exception is provided.
Applications must address the challenge in a way that can lead to or make a breakthrough and have major impact.
The FY25 Breakthrough Award mechanism contains three different funding levels designed to support major (but not all) stages of research that will lead to clinical application.
Each level has a defined research scope.
The current program announcement discusses the Breakthrough Award Level 3. Distinctive Features:· For this funding mechanism, small-scale clinical trials are allowed but not required.
Applications proposing projects with a clinical trial should be submitted under the Clinical Trial option.· The research team must include two or more breast cancer consumer advocates.· This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI.
For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage.
Be advised, applications may be withdrawn if both the initiating and partnering applications are not submitted by the full application deadline or if the initiating or partnering application is administratively withdrawn.
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-14-003.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-14-003.html
Contact:
Agency Email Description:
CDMRP Help Desk
Agency Email:
Date Posted:
2025-04-22
Application Due Date:
Archive Date:
2025-10-10
Social Entrepreneurship
Spotlight
Social Enterprise: Reaching Out to the Private Sector for Help
John Converse Townsend, a Forbes contributor, shares what can the private sector do for a social enterprise. He encourages social enterprises to reach out to corporations for help to scale up their businesses.
Learn How to Identify and Avoid Grant Scams
